Institutional Ownership Avidity Biosciences, Inc. (RNA)
This table provides information about the institutional ownership of Avidity Biosciences, Inc. (RNA). We have compiled data on the 256 institutions that hold shares in the stock, with a total of 107 Million shares, which have been reported (via 13F filing form) to have a value of $4.56 Billion.
| Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
|---|---|---|---|---|---|
|
Price T Rowe Associates Inc
Baltimore, MD |
Nov 14, 2024 Q3 2024 |
10,633,962
shares
|
$460 Million
0.06% of portfolio
|
Q3 2024
Reduced 2.59%
|
|
|
Vanguard Group Inc
Valley Forge, PA |
Nov 13, 2024 Q3 2024 |
9,226,884
shares
|
$399 Million
0.01% of portfolio
|
Q3 2024
Added 55.24%
|
|
|
Black Rock Inc.
New York, NY |
Aug 13, 2024 Q2 2024 |
8,622,513
shares
|
$373 Million
0.01% of portfolio
|
Q2 2024
Added 39.84%
|
|
|
Rtw Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
8,132,870
shares
|
$352 Million
5.95% of portfolio
|
Q3 2024
Reduced 7.65%
|
|
|
Wellington Management Group LLP
Boston, MA |
Nov 14, 2024 Q3 2024 |
7,030,949
shares
|
$304 Million
0.06% of portfolio
|
Q3 2024
Added 84.93%
|
|
|
Avoro Capital Advisors LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
6,875,000
shares
|
$297 Million
4.75% of portfolio
|
Q3 2024
Added 5.69%
|
|
|
Ra Capital Management, L.P.
Boston, MA |
Nov 14, 2024 Q3 2024 |
6,300,408
shares
|
$272 Million
4.04% of portfolio
|
Q3 2024
Added 16.67%
|
|
|
Janus Henderson Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
4,896,166
shares
|
$212 Million
0.12% of portfolio
|
Q3 2024
Added 33.89%
|
|
|
State Street Corp
Boston, MA |
Nov 14, 2024 Q3 2024 |
4,706,106
shares
|
$204 Million
0.01% of portfolio
|
Q3 2024
Added 41.75%
|
|
|
Adage Capital Partners Gp, L.L.C.
Boston, MA |
Nov 14, 2024 Q3 2024 |
3,079,374
shares
|
$133 Million
0.26% of portfolio
|
Q3 2024
Reduced 9.35%
|
|
|
Geode Capital Management, LLC
Boston, MA |
Nov 12, 2024 Q3 2024 |
2,585,303
shares
|
$112 Million
0.01% of portfolio
|
Q3 2024
Added 14.56%
|
|
|
Casdin Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
2,084,841
shares
|
$90.2 Million
7.44% of portfolio
|
Q1 2024
Added 77.32%
|
|
|
Boxer Capital, LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
1,727,388
shares
|
$74.7 Million
4.21% of portfolio
|
Q1 2024
Added 54.05%
|
|
|
Polar Capital Holdings PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
1,542,126
shares
|
$66.7 Million
0.43% of portfolio
|
Q3 2024
Added 38.42%
|
|
|
Siren, L.L.C.
New York, NY |
Nov 13, 2024 Q3 2024 |
1,440,736
shares
|
$62.3 Million
3.31% of portfolio
|
Q3 2024
New holding
|
|
|
Bank Of America Corp
Charlotte, NC |
Nov 14, 2024 Q3 2024 |
1,343,019
shares
|
$58.1 Million
0.01% of portfolio
|
Q3 2024
Added 602.16%
|
|
|
Artisan Partners Limited Partnership
Milwaukee, WI |
Nov 12, 2024 Q3 2024 |
1,329,279
shares
|
$57.5 Million
0.1% of portfolio
|
Q3 2024
Reduced 30.11%
|
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
1,108,647
shares
|
$47.9 Million
0.05% of portfolio
|
Q3 2024
Added 50.01%
|
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
1,058,560
shares
|
$45.8 Million
0.01% of portfolio
|
Q3 2024
Reduced 12.42%
|
|
|
Cormorant Asset Management, LP
Boston, MA |
Nov 14, 2024 Q3 2024 |
1,050,000
shares
|
$45.4 Million
3.38% of portfolio
|
Q3 2024
Added 147.06%
|
|
|
Orbimed Advisors LLC
San Diego, CA |
Nov 14, 2024 Q3 2024 |
1,044,805
shares
|
$45.2 Million
1.13% of portfolio
|
Q3 2024
Added 47.89%
|
|
|
Charles Schwab Investment Management Inc
San Francisco, CA |
Nov 12, 2024 Q3 2024 |
990,182
shares
|
$42.8 Million
0.01% of portfolio
|
Q3 2024
Added 24.85%
|
|
|
Northern Trust Corp
Chicago, IL |
Nov 13, 2024 Q3 2024 |
971,131
shares
|
$42 Million
0.01% of portfolio
|
Q3 2024
Added 27.77%
|
|
|
Man Group PLC
London, X0 |
Nov 14, 2024 Q3 2024 |
910,131
shares
|
$39.4 Million
0.12% of portfolio
|
Q3 2024
New holding
|
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
874,747
shares
|
$37.8 Million
0.01% of portfolio
|
Q3 2024
Added 60.78%
|